Hair Flag Sign: Macroscopic and Trichoscopic Feature of Hair Regrowth in Alopecia Areata

2021 ◽  
Author(s):  
L.T. Fernández ◽  
D.E. Kubelis‐López ◽  
F.Z. Muñoz‐Garza ◽  
J. Ocampo‐Candiani ◽  
E.L. Alba‐Rojas
Keyword(s):  
Alopecia Areata ◽  
Hair Regrowth

Spontaneous hair regrowth in eight patients with severe alopecia areata

2018 ◽  
Vol 59 (4) ◽  
pp. e318-e319
Author(s):  
Pablo Fernandez-Gonzalez ◽  
David Saceda-Corralo ◽  
Cristina Pindado-Ortega ◽  
Diego Buendia-Castaño ◽  
Montserrat Fernández-Guarino ◽  
...  
Keyword(s):  
Alopecia Areata ◽  
Hair Regrowth

scholarly journals Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata

2018 ◽  
Vol 154 (10) ◽  
pp. 1145 ◽  
Author(s):  
Solam Lee ◽  
Beom Jun Kim ◽  
Young Bin Lee ◽  
Won-Soo Lee
Keyword(s):  
Alopecia Areata ◽  
Hair Regrowth

Targetoid pattern of hair regrowth in alopecia areata: a case report

2009 ◽  
Vol 34 (3) ◽  
pp. 413-413 ◽  
Author(s):  
L. D. El-Dars ◽  
S. Kamath ◽  
R. Logan
Keyword(s):  
Case Report ◽  
Alopecia Areata ◽  
Hair Regrowth

Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata

2011 ◽  
Vol 27 (2) ◽  
pp. 431-436 ◽  
Author(s):  
Tongyu Cao Wikramanayake ◽  
Rosa Rodriguez ◽  
Sonal Choudhary ◽  
Lucia M. Mauro ◽  
Keyvan Nouri ◽  
...  
Keyword(s):  
Mouse Model ◽  
Alopecia Areata ◽  
Hair Regrowth

scholarly journals Topical Immunomodulation with Diphenlycyclopropenone for Alopecia Areata

2019 ◽  
Vol 77 (2) ◽  
pp. 139-142
Author(s):  
Ana Sofia Borges ◽  
Ana Brasileiro ◽  
Rita Ramos Pinheiro ◽  
André Lencastre
Keyword(s):  
Prognostic Factors ◽  
Treatment Option ◽  
Alopecia Areata ◽  
Age At Onset ◽  
Treatment Interruption ◽  
Response To Treatment ◽  
Hair Regrowth ◽  
Number Of Patients ◽  
Poor Treatment ◽  
Poor Treatment Outcome

Introduction: Topical immunotherapy with diphenylcyclopropenone is a treatment option for patients with refractory or extensive alopecia areata. The aim of this study was to evaluate the clinical efficacy and tolerability of diphenylcyclopropenone therapy, in patients with alopecia areata, and identify possible prognostic factors that predict response to treatment. Methods: We conducted a retrospective study that included all patients diagnosed with alopecia areata and treated with diphenylcyclopropenone at our Department. Results: Twenty one patients were included for analysis (15 females and 6 males). Overall, nine patients (42.9%) had some hair regrowth with diphenylcyclopropenone therapy. Of these, five (55.6%) achieved pigmented terminal hair regrowth but with persistent patches of alopecia. Only one patient achieved > 90% of hair regrowth. Older age at onset, broader extent of alopecia at baseline and presence of nail dystrophy were all negative prognostic factors (p < 0.05). Atopy and thyroid dysfunction were not statistically significant as predictors of poor treatment outcome. Adverse effects were documented in 15 patients, most of them were mild and did not lead to treatment interruption. Conclusion: Diphenylcyclopropenone therapy is a viable treatment option in patients with extensive alopecia areata, although the response is partial in the majority of the cases. Limitations of this study include its retrospective nature and the limited number of patients.

scholarly journals Effect of Polarized Light Therapy on Hair Regrowth in Alopecia Areata

2018 ◽  
Vol 86 (9) ◽  
pp. 2959-2965
Author(s):  
HEBA A. EID, M.Sc.; MOHAMED M. KHALAF, Ph.D. ◽  
HEBA M. DIAB, M.D.; WALID A. ABOUEL-NAGA, Ph.D.
Keyword(s):  
Alopecia Areata ◽  
Polarized Light ◽  
Light Therapy ◽  
Hair Regrowth

Hair regrowth following TNF-α blockade in coexisting psoriasis vulgaris and alopecia areata

2013 ◽  
Vol 23 (4) ◽  
pp. 537-537 ◽  
Author(s):  
Sachiko Ono ◽  
Yoshiki Miyachi ◽  
Akiko Arakawa
Keyword(s):  
Alopecia Areata ◽  
Psoriasis Vulgaris ◽  
Hair Regrowth ◽  
Tnf Α
Sign in / Sign up

Export Citation Format

Share Document